> top > docs > PMC:7408073 > spans > 324-670 > annotations

PMC:7408073 / 324-670 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T4 65-68 Body_part denotes RAS http://purl.obolibrary.org/obo/UBERON_0018229

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
21 193-196 Gene denotes ACE Gene:59272
22 201-205 Gene denotes ACE2 Gene:59272
23 339-344 Gene denotes renin Gene:5972
27 117-123 Species denotes humans Tax:9606
28 270-278 Species denotes patients Tax:9606
30 312-317 Chemical denotes metal MESH:D008670
32 261-269 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T4 261-269 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1177 117-123 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T48692 133-134 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T4 65-68 Chemical denotes RAS http://purl.obolibrary.org/obo/CHEBI_63620
T5 69-87 Chemical denotes pathway inhibitors http://purl.obolibrary.org/obo/CHEBI_76932
T6 77-87 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T7 166-176 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T8 206-210 Chemical denotes zinc http://purl.obolibrary.org/obo/CHEBI_27363|http://purl.obolibrary.org/obo/CHEBI_30185
T10 319-323 Chemical denotes zinc http://purl.obolibrary.org/obo/CHEBI_27363|http://purl.obolibrary.org/obo/CHEBI_30185
T12 325-334 Chemical denotes chelators http://purl.obolibrary.org/obo/CHEBI_38161

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T5 19-296 Sentence denotes Based purely on experimental studies in which RAS pathway inhibitors were administered in vivo to humans/rodents, a reasonable hypothesis of using inhibitors that block both ACE and ACE2 zinc metalloproteases and their downstream pathways in COVID-19 patients will be proposed.